This latest update follows an initial announcement from the hospital in February, saying it notified 18 patients of a possible exposure to the disease after an operation on a patient, who was later found to have CJD. The instruments used in the operation were sterilized, but they did not undergo the enhanced sterilization procedures used for instruments involved in surgery on suspected or confirmed CJD cases.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Three of the 18 originally notified patients are no longer considered at risk, according to the report.
Caryn Klebba, Novant spokesperson, said in the report the North Carolina Department of Health Service Regulation conducted a survey in February and “determined that we had taken the necessary steps to prevent this from happening in the future.”
More Articles on Infection Control:
Treating Neonates With Antibiotics Paradoxically Increases Infection Risks
Scientists Record First-Ever Vancomycin-Resistant MRSA-Caused Bloodstream Infection
Level of Drug Resistance Does Not Predict HAI Mortality, Study Finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
